Maxim V. Skulachev,Vladimir P. Skulachev,Andrei A. Zamyatin,Evgeny S. Efremov,Vadim N. Tashlitsky,Lev S. Yaguzhinsky,Galina A. Korshunova,Natalya V. Sumbatyan,Yury N. Antonenko,Inna I. Severina,Boris
申请号:
US13470823
公开号:
US09233903B2
申请日:
2012.05.14
申请国别(地区):
US
年份:
2016
代理人:
摘要:
The present disclosure provides purified pharmaceutical preparations comprising oxidized SkQ1, wherein no individual impurity exceeds 1.5%, the total impurity content of the preparation does not exceed 4.0%, and the content of reduced SkQ1 is not greater than 10%, the structure of oxidized SkQ1 being: